Oncolytics Biotech Inc.

ONCY | NASDAQ

Price Alert Chart Builder DCF Calculator

$0.73

-$0.04 (-4.74%)

Sep 22, 2026, 2:16 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-28.76M	-22.79M	-20.92M	-18.3M	-26.3M	-22.51M
Depreciation & Amortization	70K	87K	303.78K	288.83K	452K	446K
Stock-Based Compensation	3.1M	1.98M	1.56M	1.75M	3.83M	2.56M
Other Working Capital	-1.76M	2.56M	949.04K	33.89K	-132K	-1.77M
Other Non-Cash Items	4.29M	-1.68M	-3.72M	-1.24M	501K	-2.78M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	1.18M	2.52M	1.33M	288.09K	-908K	210K
Operating Cash Flow	-20.11M	-19.88M	-21.44M	-17.21M	-22.43M	-22.07M
Capital Expenditures	-6K	-174K	-6.03K	-40.52K	-286K	-29K
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	-14.99M	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	15.25M	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-6K	-174K	15.24M	-15.03M	-286K	-29K
Debt Repayment	n/a	-242.48K	-306.8K	-280.73K	-366K	-461K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-27K	242.48K	n/a	n/a	n/a	1.94M
Financial Cash Flow	14.12M	5.03M	24.12M	8.99M	33.02M	39.77M
Net Cash Flow	-5.88M	-15.32M	17.52M	-21.81M	10.04M	17.07M
Free Cash Flow	-20.12M	-20.06M	-21.45M	-17.25M	-22.72M	-22.1M
Adj. Free Cash Flow	-23.22M	-22.04M	-23.01M	-19M	-26.55M	-24.66M
Maintenance CapEx	-6K	-87K	-6.03K	-40.52K	-286K	-29K
Growth CapEx	n/a	-87K	n/a	n/a	n/a	n/a
Owner Earnings	-20.12M	-19.97M	-21.45M	-17.25M	-22.72M	-22.1M